15 top medical organizations agree on hormone therapy use

10 years have passed since Women's Health Initiative raised questions

2012-07-10

(Press-News.org) (July 9, 2012) — After 10 years of debate regarding the risks and benefits of hormone therapy, 15 top medical organizations have come together to issue a statement of agreement regarding the benefits of hormone therapy for symptomatic menopausal women. It was July 9, 2002, when the controversial, highly publicized Women's Health Initiative (WHI) published its assessment of hormone therapy for the prevention of chronic disease and concluded that risks exceeded benefits. The new joint statement, prepared by The North American Menopause Society (NAMS), the American Society for Reproductive Medicine (ASRM), and The Endocrine Society, concludes that hormone therapy is still an acceptable treatment for menopausal symptoms. This statement has been endorsed by 12 other leading organizations in women's health.

The purpose of this statement is to reassure women and their providers that hormone therapy is acceptable and relatively safe for healthy, symptomatic, recently postmenopausal women. Over the last 10 years, there has been a complete abandonment of hormone therapy in some settings accompanied by reluctance to treat women who would benefit from relief of their symptoms. As a result, some women have sought unproven alternative therapies.

"We believe that too many symptomatic women are missing out on the proven benefits of hormone therapy because the results of the WHI, which studied the long-term use of hormones to prevent chronic disease, were misinterpreted for women with menopausal symptoms" said Dr. Margery Gass, Executive Director for NAMS. "Women and clinicians are frustrated by the many conflicting recommendations. That's why we initiated this effort to bring these notable medical organizations together in agreement regarding the use of hormone therapy."

Roger Lobo, MD, Past President of the American Society for Reproductive Medicine added, "Physicians can help patients determine, based on their own particular characteristics and history, whether or not they are good candidates for hormone therapy and what type of HT will provide them the greatest relief at the lowest risk. A decade of research and analysis has shown us that the generalized conclusions of the WHI do not apply to younger women at the beginning of the menopausal transition."

"The results of the WHI and the conflicting reports that followed led many women to believe hormone therapy may not be a safe treatment for menopausal symptoms," said Janet E. Hall, MD, immediate Past President of The Endocrine Society. "We want women to know that there are options out there for relief of their menopausal symptoms. The level of risk depends on the individual, her health history, age, and the number of years since her menopause began."

When it comes to the safety and effectiveness of hormone therapy, one commonly heard lament is, "Even the experts don't agree." This statement was prepared to address this misperception by presenting evidence-based key concepts about hormone therapy to assist women and their clinicians in making informed decisions about use of hormone therapy when appropriate.

Major points of agreement among the societies include:

Hormone therapy is an acceptable option for the relatively young (up to age 59 or within 10 years of menopause) and healthy women who are bothered by moderate to severe menopausal symptoms. Individualization is key in the decision to use hormone therapy. If women have only vaginal dryness or discomfort with intercourse, the preferred treatments are low doses of vaginal estrogen. Women who still have a uterus need to take a progestogen (progesterone or a similar product) along with the estrogen to prevent cancer of the uterus. Women who have had their uterus removed can take estrogen alone. Both estrogen therapy and estrogen with progestogen therapy increase the risk of blood clots in the legs and lungs, similar to birth control pills, patches, and rings. Although the risks of blood clots and stroke increase with either type of hormone therapy, the risk is rare in women ages 50-59. An increased risk in breast cancer is seen with 5 or more years of continuous estrogen with progestogen therapy, possibly earlier. The risk decreases after hormone therapy is stopped.

### The statement is being published in the journals of The North American Menopause Society, the American Society for Reproductive Medicine, and The Endocrine Society and has been endorsed by the Academy of Women's Health, the American Academy of Family Physicians, the American Academy of Physician Assistants, the American Association of Clinical Endocrinologists, the American Medical Women's Association, the Asociación Mexicana para el Estudio del Climaterio, the Association of Reproductive Health Professionals, the National Association of Nurse Practitioners in Women's Health, the National Osteoporosis Foundation, the Society for the Study of Reproduction, the Society of Obstetricians & Gynaecologists of Canada, and the SIGMA Canadian Menopause Society.

The joint hormone therapy statement can be accessed on the websites of The North American Menopause Society (www.menopause.org), the American Society for Reproductive Medicine (www.asrm.org), and The Endocrine Society (www.endo-society.org).

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field—including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education—makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit our website: www.menopause.org

The American Society for Reproductive Medicine, founded in 1944, is an organization of 8,000 physicians, researchers, nurses, technicians and other professionals dedicated to advancing knowledge and expertise in reproductive biology. Affiliated societies include the Society for Assisted Reproductive Technology, the Society for Male Reproduction and Urology, the Society for Reproductive Endocrinology and Infertility, the Society of Reproductive Surgeons, and the Society of Reproductive Biologists and Technologists. Website: www.asrm.org

Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 15,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, MD. To learn more about the Society and the field of endocrinology, visit our website: http://www.endo-society.org. Contact:

The North American Menopause Society
Eileen Petridis
Phone: (216) 696-0229
epetridis@fallscommunications.com

American Society for Reproductive Medicine
Eleanor Nicoll
Phone: (202) 863-2439
enicoll@asrm-dc.org

The Endocrine Society
Aaron Lohr
Phone: (240) 482-1380
alohr@endo-society.org

ELSE PRESS RELEASES FROM THIS DATE:

New evidence for link between obesity and circle of friends

2012-07-10

MAYWOOD, IL. -- A Loyola study of high school students provides new evidence that a person's circle of friends may influence his or her weight. Students were more likely to gain weight if they had friends who were heavier than they were. Conversely, students were more likely to get trimmer -- or gain weight at a slower pace -- if their friends were leaner than they were. Results of the study by David Shoham, PhD, and colleagues are published in the journal PLoS ONE. Shoham is an assistant professor in the Department of Preventive Medicine & Epidemiology of Loyola ...

Hormone curbs depressive-like symptoms in stressed mice

2012-07-10

SAN ANTONIO, Texas, U.S.A. (July 9, 2012) — A hormone with anti-diabetic properties also reduces depression-like symptoms in mice, researchers from the School of Medicine at the UT Health Science Center San Antonio reported today. All types of current antidepressants, including tricyclics and selective serotonin reuptake inhibitors, increase the risk for type 2 diabetes. "The finding offers a novel target for treating depression, and would be especially beneficial for those depressed individuals who have type 2 diabetes or who are at high risk for developing it," said ...

Researchers offer new approach to track former prisoners' access to community HIV care

2012-07-10

PROVIDENCE, R.I. – A new monitoring approach developed by researchers from The Miriam Hospital could close a major gap by providing the ability to track whether HIV-positive prisoners are getting the community-based HIV care they need once they are released. Reporting in the journal Virulence, researchers say this new tool could play a major role in preventing the spread of the disease and could guide future strategies to improve the quality of care for prisoners, a population disproportionately affected by HIV. "Jails and prisons are an opportunity to diagnose and ...

Regulation by proteins outside cancer cells points to potential new drug target

2012-07-10

SAN ANTONIO (July 9, 2012) – Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio. "Because this protein cascade is outside the cells, it is likely amenable to therapeutic manipulation," said lead author Yuzuru Shiio, M.D., Ph.D., assistant professor of biochemistry at the university's Greehey Children's Cancer Research Institute. "I hope our study will ultimately lead to a therapeutic strategy to ...

Iron supplements can reduce fatigue in nonanemic women

2012-07-10

Iron supplementation reduced fatigue by almost 50% in women who are low in iron but not anemic, according to the results of a clinical trial published July 9 in CMAJ (Canadian Medical Association Journal). "We found that iron supplementation for 12 weeks decreased fatigue by almost 50% from baseline, a significant difference of 19% compared with placebo, in menstruating iron-deficient nonanemic women with unexplained fatigue and ferritin levels below 50 μg/L," writes Dr. Bernard Favrat, Department of Ambulatory Care and Community Medicine, University of Lausanne, ...

Tiny bubbles snap carbon nanotubes like twigs

2012-07-10

HOUSTON – (July 9, 2012) -- What's 100 times stronger than steel, weighs one-sixth as much and can be snapped like a twig by a tiny air bubble? The answer is a carbon nanotube -- and a new study by Rice University scientists details exactly how the much-studied nanomaterials snap when subjected to ultrasonic vibrations in a liquid. "We find that the old saying 'I will break but not bend' does not hold at the micro- and nanoscale," said Rice engineering researcher Matteo Pasquali, the lead scientist on the study, which appears this month in the Proceedings of the National ...

University of Miami-led study finds winds played important role in keeping oil away from S. Fla.

2012-07-10

MIAMI – July 9, 21012 -- The Deepwater Horizon oil spill in spring 2010 is the largest oil spill in the history of the United States, with more than 200 million gallons of crude oil released at about 1,500 m. depth off the Mississippi Delta in the Gulf of Mexico. At the time of the accident, the proximity of the intense Loop Current, flowing from the Yucatan Channel to the Florida Straits, raised major concerns that the oil at the surface of the ocean would be headed toward the South Florida and East Atlantic coastal areas. However, the dominant transport of oil and oil ...

Lax gun ownership laws could impact ability of high-risk individuals to purchase firearms

2012-07-10

Sixty percent of persons incarcerated for gun crimes in the thirteen U.S. states with the most lax standards for legal firearm ownership were not legally prohibited from possessing firearms when they committed the crime that led to their incarceration. According to the study by researchers at the Johns Hopkins Bloomberg School of Public Health, 31 percent of these gun offenders were old enough to possess a firearm and had no prior disqualifying record. But 29 percent had criminal records or would have been too young to legally possess a firearm in states with the strictest ...

Turning off key piece of genetic coding eliminates toxic effect of statins, SLU research finds

2012-07-10

ST. LOUIS -- In research funded by the National Institutes of Health and the American Heart Association and published in EMBO Molecular Medicine, Saint Louis University investigator Ángel Baldán, Ph.D., found that the microRNA miR-33 plays a key role in regulating bile metabolism. Further, the research suggests that, in an animal model, the manipulation of this microRNA can improve the liver toxicity that can be caused by statins. "As we learn more about the way cholesterol is moved and metabolized through the body, we have more tools at our disposal to try to limit ...

Technique spots disease using immune cell DNA

2012-07-10

PROVIDENCE, R.I. [Brown University] — When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers. The key to the new technique, described in two recent papers, ...

15 top medical organizations agree on hormone therapy use

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: